Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Artículo en Inglés | MEDLINE | ID: mdl-9774175

RESUMEN

The effect of the Helicobacter pylori (H. pylori) fatty acid cis 9,10-methyleneoctadecanoic acid (MOA) on gastric acid secretion was studied in isolated guinea-pig parietal cells. MOA (1 and 3 micromol/l) stimulated basal and enhanced histamine- and dibutyryl cyclic AMP-stimulated acid secretion in parietal cells. MOA increased intracellular free [Ca2+]i concentration in a concentration-dependent manner. The source of [Ca2+]i was extracellular as demonstrated by depletion of [Ca2+]i with EGTA. Furthermore, MOA caused activation of parietal cell protein kinase C (PKC). The effect of MOA upon PKC activation was [Ca2+]i-dependent but did not require phosphatidylserine as phospholipid co-factor. Similarly to the effect of diolein, MOA increased the stimulatory effect of phosphatidylserine at low [Ca2+]i concentrations. Treatment of parietal cells with MOA caused translocation of PKC from the cytosol to the membrane-associated cell fraction. We propose that MOA stimulates parietal cell acid secretion presumably by an increase of cytosolic free [Ca2+]i concentrations and PKC activation.


Asunto(s)
Señalización del Calcio/efectos de los fármacos , Ácidos Grasos/farmacología , Ácido Gástrico/metabolismo , Helicobacter pylori/química , Células Parietales Gástricas/metabolismo , Proteína Quinasa C/metabolismo , 1-Metil-3-Isobutilxantina/farmacología , Aminopirina/metabolismo , Animales , Bucladesina/farmacología , Carbacol/farmacología , Diglicéridos/farmacología , Activación Enzimática , Ácidos Grasos/análisis , Cobayas , Histamina/farmacología , L-Lactato Deshidrogenasa/metabolismo , Células Parietales Gástricas/efectos de los fármacos , Células Parietales Gástricas/microbiología , Fosfatidilserinas/farmacología , Inhibidores de Fosfodiesterasa/farmacología , Proteína Quinasa C/antagonistas & inhibidores , Estaurosporina/farmacología
2.
Arzneimittelforschung ; 45(6): 697-700, 1995 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-7646573

RESUMEN

The effect of the flavonoids flavone, flavanone and quercetin on parietal cell acid production, H+/K(+)-ATPase activity, gastric mucosal prostaglandin E2 biosynthesis and Helicobacter pylori growth was studied. All flavonoids inhibited acid production in isolated parietal cells in response to histamine and dibutyryl-cAMP stimulation (IC50 values between 26 and 139 mumol/l) and inhibited H+/K(+)-ATPase activity. Inhibition of H+/K(+)-ATPase activity was dependent on the ATP concentration. Fluorescence measurements showed that flavanone reacts with ATP. These findings indicate that the inhibitory action of flavonoids on H+/K(+)-ATPase activity is related to their ability to complex ATP. Flavone and flavanone (10 and 100 mumol/l) stimulated prostaglandin E2 production in isolated gastric mucosal cells. Furthermore, the compounds inhibited Helicobacter pylori growth in a concentration-dependent manner. From these finding it appears that flavonoids are a group of compounds which could have a therapeutic potential for treatment of gastrointestinal diseases associated with Helicobacter pylori infection.


Asunto(s)
Flavanonas , Flavonoides/farmacología , Mucosa Gástrica/metabolismo , Helicobacter pylori/efectos de los fármacos , Helicobacter pylori/crecimiento & desarrollo , Células Parietales Gástricas/metabolismo , Prostaglandinas/biosíntesis , Adenosina Trifosfato/metabolismo , Animales , Dinoprostona/biosíntesis , Ácido Gástrico/metabolismo , Mucosa Gástrica/citología , Mucosa Gástrica/efectos de los fármacos , Cobayas , ATPasa Intercambiadora de Hidrógeno-Potásio/metabolismo , Técnicas In Vitro , Células Parietales Gástricas/efectos de los fármacos , Quercetina/farmacología , Porcinos
3.
Pharmacology ; 50(5): 333-7, 1995 May.
Artículo en Inglés | MEDLINE | ID: mdl-7667394

RESUMEN

The effects of various types of antiulcer agents against Helicobacter pylori F1-ATPase were studied. ATPase was released into the aqueous phase (i.e., solubilized) by sonication. The enzyme activity depended on Mg2+, but not Ca2+. The maximum activity occurred at an ATP/Mg2+ ratio of 1/5 and at pH 7.5. Mg(2+)-dependent ATPase activity was inhibited by sodium azide and the monovalent cations K+ and Na+, but not by oligomycin, dicyclohexylcarbodiimide, ouabain, or SCH 28080. The antiulcer agents ranitidine, pirenzepine, aluminum hydroxide, and sucralfate failed to influence H. pylori F1-ATPase. In contrast, bismuth subcitrate and the H+/K(+)-ATPase inhibitor omeprazole inhibited the enzyme. Inhibition was prevented and reversed by the mercaptan glutathione, indicating that both drugs interfere with sulfhydryl groups of the enzyme. The data suggest that bismuth subcitrate and omeprazole owe their antibacterial activity against H. pylori, at least in part, to inhibition of F1-ATPase, an enzyme involved in bacterial energy metabolism.


Asunto(s)
Antiulcerosos/farmacología , Helicobacter pylori/enzimología , Omeprazol/farmacología , Compuestos Organometálicos/farmacología , ATPasas de Translocación de Protón/antagonistas & inhibidores , Solubilidad
4.
Gut ; 35(9): 1176-80, 1994 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-7959221

RESUMEN

Helicobacter pylori and the fatty acids produced by this organism were compared for their acid inhibitory activity in isolated parietal cells and their interaction with gastric H+/K(+)-ATPase. H pylori (intact organisms, sonicates, methanolic extracts, and extracts from culture medium) and the fatty acids cis 9,10-methyleneoctadecanoic acid and tetradecanoic acid inhibited at fairly high concentrations histamine- and dibutyryl cyclic adenosine monophosphate stimulated acid production in isolated parietal cells, dissipated (with a slow onset) the H+/K(+)-ATPase created H+ gradient in gastric membrane vesicles, and inhibited H+/K(+)-ATPase activity in a concentration dependent manner. The inhibitory potency of H pylori and the fatty acids in relation to H+/K(+)-ATPase depended on the amount of membrane protein. Bovine serum albumin prevented enzyme inhibition and proton dissipation from gastric vesicles. The data indicate that H pylori establishes its antisecretory action in parietal cells by blocking H+/K(+)-ATPase activity and also by a detergent action at the apical parietal cell membrane. The fatty acids cis 9,10-methyleneoctadecanoic acid and tetradecanoic acid are probably the acid inhibitory factors secreted by H pylori.


Asunto(s)
Ácidos Grasos/metabolismo , Mucosa Gástrica/metabolismo , ATPasa Intercambiadora de Hidrógeno-Potásio/metabolismo , Helicobacter pylori/metabolismo , Animales , Células Cultivadas , Depresión Química , Represión Enzimática , Ácidos Grasos/farmacología , Ácido Gástrico/metabolismo , Mucosa Gástrica/citología , Mucosa Gástrica/efectos de los fármacos , Cobayas , Proteínas de la Membrana/metabolismo , Ácido Mirístico , Ácidos Mirísticos/farmacología , Protones
5.
Mol Microbiol ; 11(5): 885-96, 1994 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-8022265

RESUMEN

Within the capsule gene complex (cps) of Neisseria meningitidis B a 5.5 kb DNA fragment encodes proteins with strong homologies to enzymes of the lipopolysaccharide biosynthetic pathway of Salmonella typhimurium and Escherichia coli, GalE, RfbB, RfbC and RfbD. A meningococcal galE mutant expressed a truncated lipooligosaccharide (LOS), which terminated at the glucose residue between inner and outer core, and a second galE gene present outside the cps cluster was found to be transcriptionally and functionally inactive and, thus, unable to complement this defect. Because of the defect in the outer core, the LOS of the galE-defective meningococcal mutant was not sialylated. In contrast, carbohydrate analysis of the LOS of an rfb-defective meningococcal mutant revealed no difference from the LOS of the wild-type strain, suggesting that the rfb genes are inactive. This was supported by Northern blot analysis, which showed that expression of the rfb gene products was transcriptionally regulated. The inability of the meningococcal galE mutant, which cannot sialylate the LOS, allowed us to investigate the significance of LOS sialylation in relation to the presence of the polysialic acid capsule. Sialylated LOS, but not the polysialic acid capsule, is necessary to confer complete serum resistance on the meningococcus by inhibition of the alternative complement pathway.


Asunto(s)
Proteínas Bacterianas/genética , Carbohidrato Epimerasas/genética , Genes Bacterianos , Hidroliasas/genética , Lipopolisacáridos/metabolismo , Neisseria meningitidis/genética , UDPglucosa 4-Epimerasa , Secuencia de Aminoácidos , Proteínas Bacterianas/metabolismo , Secuencia de Bases , Carbohidrato Epimerasas/metabolismo , Secuencia de Carbohidratos , Vía Alternativa del Complemento , Proteínas del Sistema Complemento/farmacología , Farmacorresistencia Microbiana , Enterobacteriaceae/genética , Hidroliasas/metabolismo , Datos de Secuencia Molecular , Ácido N-Acetilneuramínico , Neisseria meningitidis/efectos de los fármacos , Neisseria meningitidis/metabolismo , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Ácidos Siálicos/fisiología , Especificidad de la Especie
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA